Mimedx (MDXG) Current Assets (2010 - 2026)
Mimedx's (MDXG) quarterly Current Assets came in at $240.3 million in Q1 2026, up 20.1% year-on-year from $200.1 million in Q1 2025, and down 13.39% quarter-over-quarter from $277.5 million in Q4 2025.
Mimedx (MDXG) Current Assets (2010 - 2026) Analysis & Trends
Mimedx has disclosed Current Assets across 17 years of filings, most recently posting $240.3 million for Q1 2026.
- Current Assets for Q1 2026 came in at $240.3 million, up 20.1% year-over-year; the trailing twelve-month figure through Mar 2026 was $240.3 million (up 20.1% YoY), and the FY2025 annual result was $277.5 million, up 44.6% from the prior year.
- Current Assets came in at $240.3 million for Q1 2026 at Mimedx, down from $277.5 million in the prior quarter.
- In the past five years, Current Assets ranged from a high of $277.5 million in Q4 2025 to a low of $131.0 million in Q2 2022.
- The 5-year median for Current Assets is $154.5 million (2023), against an average of $175.2 million.
- Across the five-year window, Current Assets decreased 11.3% in 2022 and jumped 47.61% in 2025, its largest moves.
- Mimedx's Current Assets stood at $134.2 million in 2022, then rose by 22.4% to $164.3 million in 2023, then climbed by 16.82% to $191.9 million in 2024, then surged by 44.6% to $277.5 million in 2025, then fell by 13.39% to $240.3 million in 2026.
- The last three Current Assets figures came in at $240.3 million (Q1 2026), $277.5 million (Q4 2025), and $254.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 37.31 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 521.86 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 10.37 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.25 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 3.59 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 7.63 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 11.73 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 600.85 Mn |
| 10 | Mimedx | 546.28 Mn | 386.51 Mn | 41.62 Mn | 240.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 240.33 Mn |
| Dec 31, 2025 | 277.47 Mn |
| Sep 30, 2025 | 254.10 Mn |
| Jun 30, 2025 | 220.88 Mn |
| Mar 31, 2025 | 200.11 Mn |
| Dec 31, 2024 | 191.89 Mn |
| Sep 30, 2024 | 172.14 Mn |
| Jun 30, 2024 | 154.02 Mn |
| Mar 31, 2024 | 138.85 Mn |
| Dec 31, 2023 | 164.26 Mn |
| Sep 30, 2023 | 154.50 Mn |
| Jun 30, 2023 | 141.22 Mn |
| Mar 31, 2023 | 131.70 Mn |
| Dec 31, 2022 | 134.20 Mn |
| Sep 30, 2022 | 136.04 Mn |
| Jun 30, 2022 | 131.01 Mn |
| Mar 31, 2022 | 135.91 Mn |
| Dec 31, 2021 | 148.52 Mn |
| Sep 30, 2021 | 141.90 Mn |
| Jun 30, 2021 | 147.69 Mn |